StemMed

Broker's Calls

TalkMed kept at 'neutral' until return of suspended CEO Dr Ang

SINGAPORE (Feb 21): RHB is maintaining its "neutral" call on TalkMed as CEO Dr Ang Peng Tiam is still serving his eight-month suspension, which started on Jul 25 2017 and is expected to be back on March 26 or towards the end of 1Q18.
×